BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Hematopoietic cell, Valproic acid, rs2230926, VEGFA, Response to oxidative stress)
Bookmark Forward

QuickView for NF-kappaB-inducing kinase activity (biogroup)


Body Atlas

Most Correlated Tissues

  1. Endometrium
  2. Myometrium
  3. Peritoneum
  4. Kidney medulla
  5. Tonsil
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Intestinal infectious disease
  2. Pyloric ulcer
  3. Disease due to Rotavirus
  4. Protozoan infection
  5. Irritable bowel syndrome
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. IL7 protein, human
  2. stearic acid
  3. JNJ38877605
  4. Thioglycolates
  5. roscovitine
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. MAST4
  2. CHMP2B
  3. SOX5
  4. BLMH
  5. Rela
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

  1. Lymph nodes from induced experimental autoimmune encephalomyelitis (EAE) mice
  2. The Cancer Genome Atlas (TCGA) - gene expression in glioblastoma multiforme
  3. Blood from relapsing and cured tuberculosis patients
  4. L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (2 of 2)
  5. The Immunological Genome Project - Immune cell lineage differentiation and maturation
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Canc…
  2. A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic H…
  3. Study of Axitinib in Patients With Recurred or Metastatic Adenoid Cystic Carcinoma
  4. Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
  5. A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomi…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.